BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 21317179)

  • 1. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer.
    Baldwin DR; Duffy SW; Wald NJ; Page R; Hansell DM; Field JK
    Thorax; 2011 Apr; 66(4):308-13. PubMed ID: 21317179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.
    Ali N; Lifford KJ; Carter B; McRonald F; Yadegarfar G; Baldwin DR; Weller D; Hansell DM; Duffy SW; Field JK; Brain K
    BMJ Open; 2015 Jul; 5(7):e008254. PubMed ID: 26173719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report.
    Field JK; Baldwin D; Brain K; Devaraj A; Eisen T; Duffy SW; Hansell DM; Kerr K; Page R; Parmar M; Weller D; Williamson P; Whynes D;
    Thorax; 2011 Aug; 66(8):736-7. PubMed ID: 21724746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European and North American lung cancer screening experience and implications for pulmonary nodule management.
    Nair A; Hansell DM
    Eur Radiol; 2011 Dec; 21(12):2445-54. PubMed ID: 21830100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.
    Field JK; Duffy SW; Baldwin DR; Whynes DK; Devaraj A; Brain KE; Eisen T; Gosney J; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rassl DM; Rintoul RC; Screaton NJ; Wald NJ; Weller D; Williamson PR; Yadegarfar G; Hansell DM
    Thorax; 2016 Feb; 71(2):161-70. PubMed ID: 26645413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.
    Brain K; Lifford KJ; Carter B; Burke O; McRonald F; Devaraj A; Hansell DM; Baldwin D; Duffy SW; Field JK
    Thorax; 2016 Nov; 71(11):996-1005. PubMed ID: 27471048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.
    Brain K; Carter B; Lifford KJ; Burke O; Devaraj A; Baldwin DR; Duffy S; Field JK
    Thorax; 2017 Oct; 72(10):912-918. PubMed ID: 28710339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol and Rationale for the International Lung Screening Trial.
    Lim KP; Marshall H; Tammemägi M; Brims F; McWilliams A; Stone E; Manser R; Canfell K; Weber M; Connelly L; Bowman RV; Yang IA; Fogarty P; Mayo J; Yee J; Myers R; Atkar-Khattra S; Lam DCL; Rosell A; Berg CD; Fong KM; Lam S;
    Ann Am Thorac Soc; 2020 Apr; 17(4):503-512. PubMed ID: 32011914
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening.
    McRonald FE; Yadegarfar G; Baldwin DR; Devaraj A; Brain KE; Eisen T; Holemans JA; Ledson M; Screaton N; Rintoul RC; Hands CJ; Lifford K; Whynes D; Kerr KM; Page R; Parmar M; Wald N; Weller D; Williamson PR; Myles J; Hansell DM; Duffy SW; Field JK
    Cancer Prev Res (Phila); 2014 Mar; 7(3):362-71. PubMed ID: 24441672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.
    Marcus MW; Duffy SW; Devaraj A; Green BA; Oudkerk M; Baldwin D; Field J
    Thorax; 2019 Aug; 74(8):761-767. PubMed ID: 31028232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Yorkshire Kidney Screening Trial (YKST): protocol for a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal pathology within a trial of community-based CT screening for lung cancer.
    Usher-Smith JA; Godoy A; Burge SW; Burbidge S; Cartledge J; Crosbie PAJ; Eckert C; Farquhar F; Hammond D; Hancock N; Iball GR; Kimuli M; Masson G; Neal RD; Rogerson S; Rossi SH; Sala E; Smith A; Sharp SJ; Simmonds I; Wallace T; Ward M; Callister MEJ; Stewart GD
    BMJ Open; 2022 Sep; 12(9):e063018. PubMed ID: 36127097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.
    Oudkerk M; Liu S; Heuvelmans MA; Walter JE; Field JK
    Nat Rev Clin Oncol; 2021 Mar; 18(3):135-151. PubMed ID: 33046839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
    Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
    BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
    Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
    J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European randomized lung cancer screening trials: Post NLST.
    Field JK; van Klaveren R; Pedersen JH; Pastorino U; Paci E; Becker N; Infante M; Oudkerk M; de Koning HJ;
    J Surg Oncol; 2013 Oct; 108(5):280-6. PubMed ID: 23893464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
    Silva M; Pastorino U; Sverzellati N
    Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant screening of coronary artery disease and lung cancer with a new ultrafast-low-dose Computed Tomography protocol: A pilot randomised trial.
    Gaudio C; Tanzilli A; Mei M; Moretti A; Barillà F; Varveri A; Paravati V; Tanzilli G; Ciccaglioni A; Strano S; Pellegrini M; Barillari P; Pelliccia F
    Sci Rep; 2019 Sep; 9(1):13872. PubMed ID: 31554878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.